Forward to a friend |
Subscribe | The Record Archive | Contacts | bcbsm.com | Print this article
|
September 2022
Importance of statin therapy for patients with cardiovascular disease, diabetesCardiovascular disease is the leading cause of death in the United States. It’s estimated that 92.1 million American adults have one or more types of cardiovascular disease.** People with diabetes also have elevated cardiovascular risk, thought to be due, in part, to elevations in unhealthy cholesterol levels. Having unhealthy cholesterol levels places people at significant risk for developing atherosclerotic cardiovascular disease, or ASCVD. American College of Cardiology and American Heart Association guidelines state that statins of moderate or high intensity are recommended for adults with established clinical ASCVD. American Diabetes Association and AHA guidelines also recommend statins for prevention of cardiovascular disease in patients with diabetes, based on age and other risk factors. Furthermore, guidelines state that adherence to statins will aid in ASCVD risk reduction in both populations (individuals with ASCVD and those with diabetes). Tip sheets The Centers for Medicare & Medicaid Services has two Medicare Star Ratings measures to support statin therapy’s importance. To learn more about these measures, read these tip sheets: Statin Therapy for Patients with Cardiovascular Disease (SPC) **Source: Statin Therapy for Patients With Cardiovascular Disease and Diabetes - NCQA (Blue Cross Blue Shield of Michigan doesn't own or control this website.) |
|
No portion of this publication may be copied without the express written permission of Blue Cross Blue Shield of Michigan, except that BCBSM participating health care providers may make copies for their personal use. In no event may any portion of this publication be copied or reprinted and used for commercial purposes by any party other than BCBSM.
|